BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7570941)

  • 1. Posttransfusion purpura-like syndrome associated with CD36 (Naka) isoimmunization.
    Bierling P; Godeau B; Fromont P; Bettaieb A; Debili N; el-Kassar N; Rouby JJ; Vainchenker W; Duedari N
    Transfusion; 1995 Sep; 35(9):777-82. PubMed ID: 7570941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life-threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti-CD36 (Nak) isoantibody.
    Morishita K; Wakamoto S; Miyazaki T; Sato S; Fujihara M; Kaneko S; Yasuda H; Yamamoto S; Azuma H; Kato T; Ikeda H
    Transfusion; 2005 May; 45(5):803-6. PubMed ID: 15847672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36 deficiency is frequent and can cause platelet immunization in Africans.
    Lee K; Godeau B; Fromont P; Plonquet A; Debili N; Bachir D; Reviron D; Gourin J; Fernandez E; Galactéros F; Bierling P
    Transfusion; 1999 Aug; 39(8):873-9. PubMed ID: 10504124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature.
    Curtis BR; Ali S; Glazier AM; Ebert DD; Aitman TJ; Aster RH
    Transfusion; 2002 Sep; 42(9):1173-9. PubMed ID: 12430674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal/neonatal alloimmune thrombocytopenia due to anti-CD36 antibodies: antibody evaluations by CD36-transfected cell lines.
    Lin M; Xu X; Lee HL; Liang DC; Santoso S
    Transfusion; 2018 Jan; 58(1):189-195. PubMed ID: 29030871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on CD36 deficiency in South China: Two cases demonstrating the clinical impact of anti-CD36 antibodies.
    Xu X; Ye X; Xia W; Liu J; Ding H; Deng J; Chen Y; Shao Y; Wang J; Fu Y; Santoso S
    Thromb Haemost; 2013 Dec; 110(6):1199-206. PubMed ID: 23966019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD36 (Naka) sensitization with platelet-transfusion refractoriness in a liver transplant recipient.
    Ogata T; Ohto H; Yasuda H; Kawabata K; Tsuchiya T; Saito T; Gotoh M
    Transplantation; 2005 Mar; 79(5):620. PubMed ID: 15753856
    [No Abstract]   [Full Text] [Related]  

  • 8. A single-center investigational study of CD36 antigen deficiency and platelet alloantibody distribution in different populations in Northern China as well as platelet alloantibodies effect on pregnancy.
    Ma C; Wang J; Yang L; Feng Y; Fu L; Guan X; Wang S; Yu Y; Wang D
    Clin Chim Acta; 2019 Nov; 498():68-75. PubMed ID: 31421121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet CD36 deficiency is present in 2.6% of Arabian individuals and can cause NAIT and platelet refractoriness.
    Flesch BK; Scherer V; Opitz A; Ochmann O; Janson A; Steitz M; Zeiler T
    Transfusion; 2021 Jun; 61(6):1932-1942. PubMed ID: 33822386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-CD36 Mediated Platelet Transfusion Refractoriness and Related Cases After Stem Cell Transplantation].
    Zhou Y; Li LL; Zhong ZL; Liu XJ; Liu JL; Shen WD; Wu GG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):541-546. PubMed ID: 29665929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians.
    Curtis BR; Aster RH
    Transfusion; 1996 Apr; 36(4):331-4. PubMed ID: 8623134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransfusion thrombocytopenia associated with passive transfusion of a platelet-specific antibody.
    Scott EP; Moilan-Bergeland J; Dalmasso AP
    Transfusion; 1988; 28(1):73-6. PubMed ID: 3257594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoantibody specificity in post-transfusion purpura.
    Gockerman JP; Shulman NR
    Blood; 1973 Jun; 41(6):817-22. PubMed ID: 4712208
    [No Abstract]   [Full Text] [Related]  

  • 14. Refractory platelet transfusion in a patient with CD36 deficiency due to pseudothrombocytopenia.
    Yin XL; Shen WD; Chen YS; Zhou Y; Zhang XH
    Platelets; 2011; 22(3):237-40. PubMed ID: 21143025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of transfusion of platelet antibody: a case report and literature review.
    Pavenski K; Webert KE; Goldman M
    Transfusion; 2008 Sep; 48(9):1981-9. PubMed ID: 18564398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransfusion purpura associated with alloantibody specific for the platelet antigen, Pen(a).
    Simon TL; Collins J; Kunicki TJ; Furihata K; Smith KJ; Aster RH
    Am J Hematol; 1988 Sep; 29(1):38-40. PubMed ID: 2459963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransfusion purpura with antibodies against human platelet antigen-4a following checkpoint inhibitor therapy: a case report and review of the literature.
    Vu K; Leavitt AD
    Transfusion; 2018 Oct; 58(10):2265-2269. PubMed ID: 30222869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransfusion purpura. Report of a case with anti-P1A1 masked by HLA antibodies.
    Dunstan RA; Rosse WF
    Transfusion; 1985; 25(3):219-22. PubMed ID: 3159134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary refractoriness to platelet transfusion caused by Nak(a) antibody alone.
    Fujino H; Ohta K; Taniue J; Nagao N; Hino M; Yamane T; Koh KR; Takeoka Y; Hirose A; Aoyama Y; Nakamae H; Terada Y; Takubo T; Tatsumi N
    Vox Sang; 2001 Jul; 81(1):42-4. PubMed ID: 11520415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransfusion purpura following bone marrow transplantation.
    Evenson DA; Stroncek DF; Pulkrabek S; Perry EH; Radford J; Miller JS; Verfaillie C
    Transfusion; 1995 Aug; 35(8):688-93. PubMed ID: 7631411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.